Press Release – New York, NY – December 14, 2021 – Sichenzia Ross Ference LLP today announced that it represented Relmada Therapeutics, Inc. (NASDAQ: RLMD), a late-stage biotechnology company …
MJDS Allows Canadian Issuers Easy Access to the U.S. Capital Markets
Overview The Multijurisdictional Disclosure System (“MJDS”) adopted by the Securities and Exchange Commission (the “SEC”) and the Canadian Securities Administrators provides Canadian issuers a …
Continue Reading about MJDS Allows Canadian Issuers Easy Access to the U.S. Capital Markets →
Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $13.7 Million Underwritten Public Offering for Tantech Holdings Ltd.
Press Release – New York, NY – December 9, 2021 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering of Tantech …
Sichenzia Ross Ference LLP Represents Alset EHome International Inc. in $30.0 Million Underwritten Public Offering
Press Release – New York, NY – December 9, 2021 – Sichenzia Ross Ference LLP today announced that it represented Alset EHome International Inc. (NASDAQ: AEI), a diversified holdings company …
CMF Represents Mirror Biologics, Inc. $14 Million Offering
Tampa, FL, December 09, 2021 –(PR.com)– Mirror Biologics, Inc., a clinical stage immunotherapy company specializing in the development, manufacturing, commercialization and clinical translation of …
Continue Reading about CMF Represents Mirror Biologics, Inc. $14 Million Offering →
Sichenzia Ross Ference LLP Represents mCloud Technologies Corp., a Canadian Public Company, in $9.5 Million Underwritten Public Offering Made under the MJDS in the US and Uplisting to Nasdaq
Press Release – New York, NY – November 30, 2021 – Sichenzia Ross Ference LLP announced today that it represented mCloud Technologies Corp. (Nasdaq: MCLD) (TSXV: MCLD), a leading provider of …
